Hangzhou Diagens Biotechnology Co., Ltd. (HKG:2526)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
293.00
+10.80 (3.83%)
At close: Apr 20, 2026

HKG:2526 Revenue

In the year 2025, Hangzhou Diagens Biotechnology had annual revenue of 164.42M CNY with 133.72% growth. Hangzhou Diagens Biotechnology had revenue of 52.81M in the quarter ending December 31, 2025.

Revenue
164.42M CNY
Revenue Growth
+133.72%
P/S Ratio
142.33
Revenue / Employee
903.43K CNY
Employees
182
Market Cap
26.04B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025164.42M94.07M133.72%
Dec 31, 202470.35M17.51M33.13%
Dec 31, 202352.84M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition